Piramal Group s subsidiary invests Rs 110 crore in Biodeal Pharma to strengthen its infrastructure and capacities - Pharma News financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.
Piramal Alternatives, the fund management arm of the Piramal Group, has announced a Rs 110-crore ($13.2 million) investment in Noida-based Biodeal Pharmaceuticals, a contract development ..